Oliver Baumann
Net worth: 8 M $ as of 2026-08-30
Net worth: 8 M $ as of 2026-08-30
Oliver R.
Baumann is Chief Executive Officer & Director at Xlife Sciences AG since 2020, Chief Executive Officer at Akira Trading GmbH, Chairman at Akira Holding AG, Chairman & General Manager at Veraxa Biotech Holding AG, Director at Pecunia Solutions AG, Director at VERAXA Biotech AG, Director at Axenoll Life Sciences AG, and Co-Managing Director at Xrna.
Biotech GmbH.
Former roles include Chief Executive Officer at Belvoir Wealth Management AG and Co-Managing Director at x-diagnostics GmbH.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
4.08% | 2026-08-26 | 5,773,618 ( 4.08% ) | 8 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| XLIFE SCIENCES AG | Chief Executive Officer | 2019-06-30 |
Pecunia Solutions AG | Director/Board Member | - |
Axenoll Life Sciences AG | Director/Board Member | - |
Akira Holding AG | Chairman | - |
| Companies | Position | End |
|---|---|---|
Veraxa Biotech AG
Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Director/Board Member | - |
Belvoir Wealth Management AG
Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Belvoir Wealth Management AG
Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Finance |
Pecunia Solutions AG | |
Xlife Sciences AG
Xlife Sciences AG Miscellaneous Commercial ServicesCommercial Services Develops life sciences technologies | Commercial Services |
Akira Holding AG | |
Veraxa Biotech AG
Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Health Technology |
Axenoll Life Sciences AG |
Select your edition
All financial news and data tailored to specific country editions